Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

EU-India Trade Talks Must Stop

Asia Europe People’s Forum  *  Belgian Platform for Action on Health and Solidarity  *  Corporate Europe Observatory  *  India FDI Watch  *  Programme on Women’s Economic Social and Cultural Rights  *  WIDE network

Brussels, Tuesday 5 October 2010 – Civil society groups today urged the European Commission and Indian Government to halt free trade negotiations, scheduled to continue in Delhi tomorrow. In an open letter, signed by more than 100 groups, they warned that the talks would damage the livelihoods of millions of people in both India and Europe, exacerbating poverty and undermining economic and social development [1].

Talks on a free trade agreement (FTA) between the EU and India are said to be making extremely good progress with plans to push the agenda in the run up to an EU-India Summit in Brussels in December. Speaking at a press conference in Brussels, representatives from Indian and European civil society groups said that the behind-closed-door negotiations must be made more transparent – and be accountable to wider interests in society.

Research by the groups involved shows how business interests have driven the negotiating agenda – pushing the priorities of big business at the expense of small farmers, fishing communities, street traders and small businesses [2] and putting the health of millions of people at risk [3].

Dharmendra Kumar, director of India FDI Watch, told the press conference:

“There is a terrible irony in the world’s two largest supposed democracies secretly negotiating a trade agreement which will be potentially disastrous for peoples’ rights, livelihoods and for the environment. Big businesses from the EU and India have captured the agenda for these talks, at the expense of wider society. This capture is wrong and we demand an immediate halt to the negotiations. Governments must put people before profit."

Wim De Ceukelaire from the Belgian Platform for Action on Health and Solidarity, also speaking at the conference, raised concerns about the talks’ impact on access to medicines.

“India is known as the pharmacy of the developing world. It would be an outrage for Europe to undermine the Indian drug industry’s capacity to provide cheap and safe medicines to poor countries through this agreement – but that is what the EU seems to be doing."

Priti Darooka, Executive Director of Programme on Women’s Economic Social and Cultural Rights (PWESCR) told the press conference that the talks were in direct conflict with Indian government policies aimed at creating employment and protecting rights.

“The Indian government promises to provide universal basic rights including the right to food, education, health, social security and work, and yet we have a free trade agreement with which the European Union will deny people, especially women precisely these same rights. It is like the right hand gives but the left snatches it away.”

The event followed the Asia Europe People’s Forum in Brussels which brought together people from Asia and Europe to discuss Building States of Citizens for Citizens [4].

The call comes at the start of a two-day conference on “Beyond free trade – alternatives for decent work” organised by trade unions and civil society organisations in Brussels [5].

Notes:

[1] Last chance to prevent onslaught on people’s rights and livelihoods! Indian and European civil society groups call for an immediate halt to the India-EU trade negotiations See: http://www.corporateeurope.org/global-europe/content/2010/10/call-halt-e...

[2] “Trade Invaders. How Big Business is Driving the EU-India Trade Negotiations”, published by Corporate Europe Observatory and India FDI Watch, September 2010 See: http://www.corporateeurope.org/global-europe/content/2010/09/eu-india-tr...

[3] The EU’s Bilateral FTA Negotiations are a Threat to the Right to Health, Platform for Action on Health and Solidarity – Working Group on North-South Solidarity Issues, April 2010

[4] The Asia Europe People's Forum was held from 2-5 October, ahead of the Asia Europe Meeting (ASEM-8). See: http://www.aepf.info/

[5] The conference will be held on 5-6 October in Brussels. See: http://www.weed-online.org/themen/3957925.html

Related issues: 
 

A deregulation agenda is sweeping through the Commission & member states, particularly pushed by the UK.

The recent leak of many parts of TTIP, allowing us for the first time to read the negotiating position of the US, confirms our most serious concerns.

Dangerous attacks against regulations protecting public interest wouldn't be prevented by 'new' proposals.

Despite growing concerns among the European public, the new EU proposal on regulatory cooperation in TTIP does nothing to address the upcoming democratic threats.

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

While CEO is not taking a position on the UK referendum, many of our publications are relevant to those who will have a vote, or those who are following the debate.

Biodiversity collapse, the future of agriculture, politics versus science, EU States and the European Commission shifting blame on each other, industry's capture of the regulatory process through data secrecy, a Commissioner caught between Juncker, EU States, lobby groups, and his own services... The glyphosate saga, coming to the end of its first phase tomorrow, has been an entry point into many broader problems. Overview.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

The corporate lobby tour